Anna Campbell is a scientist-turned-entrepreneur with a strong background in agribusiness and biotechnology. They co-founded Zestt Wellness and Viropin Pharmaceutical, where they currently serve as CEO, focusing on the commercialization of new generation antiviral molecules. Anna's past experience includes leadership roles at AbacusBio and AgResearch, specializing in livestock genetics. They also held governance positions with Genomics Aotearoa and Otago Innovation Limited. Anna earned a PhD in Plant Biotechnology from Lincoln University and participated in the Harvard Agribusiness Seminar.
This person is not in the org chart
This person is not in any teams
This person is not in any offices